Carcinogenesis Advance Access originally published online on May 2, 2008
Carcinogenesis 2008 29(9):1717-1724; doi:10.1093/carcin/bgn098
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo
1 Department of Internal Medicine, Texas Tech University Health Sciences Center, 1400 Wallace Boulevard, Amarillo, TX 79106, USA
2 Stem Cell Transplant Program, Texas Tech University Health Sciences Center, 1400 Wallace Boulevard, Amarillo, TX 79106, USA
3 Institute of Clinical Molecular Biology, People's Hospital, Peking University, Beijing 100044, People's Republic of China
4 Division of Medical Oncology, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80010, USA
* To whom correspondence should be addressed. Tel: +1 806 354 5719; Fax: +1 806 354 5669; Email: zonghan.dai{at}ttuhsc.edu
Abl interactor (Abi) 1 was first identified as the downstream target of Abl tyrosine kinases and was found to be dysregulated in leukemic cells expressing oncogenic Bcr-Abl and v-Abl. Although the accumulating evidence supports a role of Abi1 in actin cytoskeleton remodeling and growth factor/receptor signaling, it is not clear how it contributes to Bcr-Abl-induced leukemogenesis. We show here that Abi1 gene silencing by short hairpin RNA attenuated the Bcr-Abl-induced abnormal actin remodeling, membrane-type 1 metalloproteinase clustering and inhibited cell adhesion and migration on fibronectin-coated surfaces. Although the knock down of Abi1 expression did not affect growth factor-independent growth of Bcr-Abl-transformed Ba/F3 cells in vitro, it impeded competitive expansion of these cells in non obese diabetic (NOD)/ severe combined immuno-deficiency (SCID) mice. Remarkably, the knock down of Abi1 expression in Bcr-Abl-transformed Ba/F3 cells impaired the leukemogenic potential of these cells in NOD/SCID mice. Abi1 contributes to Bcr-Abl-induced leukemogenesis in part through Src family kinases, as the knock down of Abi1 expression attenuates Bcr-Abl-stimulated activation of Lyn. Together, these data provide for the first time the direct evidence that supports a critical role of Abi1 pathway in the pathogenesis of Bcr-Abl-induced leukemia.
Abbreviations: Abi, Abl interactor; F-actin, filament actin; FBS, fetal bovine serum; MT1-MMP, membrane-type 1 metalloproteinase; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; shRNA, short hairpin RNA; WAVE, WASP-family verprolin-homologous
Received December 2, 2007; revised April 3, 2008; accepted April 8, 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T.-Y. Lin, C.-H. Huang, H.-H. Kao, G.-G. Liou, S.-R. Yeh, C.-M. Cheng, M.-H. Chen, R.-L. Pan, and J.-L. Juang Abi plays an opposing role to Abl in Drosophila axonogenesis and synaptogenesis Development, September 15, 2009; 136(18): 3099 - 3107. [Abstract] [Full Text] [PDF] |
||||
